???Heading to the AGBT General Meeting?next week?? ? Dr Rob Neely and Dr Debora Lucarelli will be in Florida showcasing our unique approach to epigenetic profiling, demonstrating its capabilities to address challenges in drug discovery, clinical trial optimisation, and diagnostic development. ? To learn more, attend one of our presentations: ???The Tagomics Clinic ???10:00-11:30am, 25 Feb ? Posters' sessions: ???Interlace: A multiomic platform for simultaneous profiling of unmethylated DNA and genomic variants for improved therapy selection and patient stratification ???Epigenomic profiling of active regulatory elements by enrichment of unmodified CpG dinucleotides ??4:45-6:10pm, 25 Feb ? We will also be sharing insights into our exclusive technology access program, delivered through our co-marketing agreement with Agilent Technologies, giving partners the opportunity to access our unified workflow for comprehensive genomic and epigenomic insights. Check out our website for more information:?https://lnkd.in/e29AkMbN ? @AGBT – Advances in Genome Biology and Technology
Our CSO, Rob Neely and CTO, Debora Lucarelli will be attending the @AGBT - Advances in Genome Biology and Technology - 23-26 of February 2025 in Marco Island. Together with Kristi Stephenson and Edward Jan, they will hold a "Tagomics Office Hours" session. The team is looking forward to meeting partners interested in accessing their novel multiomic technology, Interlace?. Drop by the Agilent suite 7016 and/or poster session.